Adenosine A2A receptor (ADORA2A) regulates inflammation, promotes tissue repair and collagen production by human dermal fibroblasts. We investigated the genetic polymorphisms of ADORA2A in susceptibility to systemic sclerosis (SSc). We genotyped 142 Korean SSc patients and 150 controls for polymorphisms of −1751A/C (rs5996696) and 1976C/T (rs5751876), to cover the promoter and all exon sequences of ADORA2A in Koreans, using TaqMan fluorogenic 5’ nuclease assay and single base primer extension assay. Neither −1751A/C nor 1976C/T polymorphism showed difference in the distribution of alleles or genotypes between patients and controls with allele frequency of 89.9% v 91.0% for −1751A (p=0.64) and 56.5% v 54.0% for 1976C (p=0.55). Our findings suggest that the role of ADORA2A in SSc may not be genetically related.
AllanoreYWipffJKahanABoileauC. Genetic basis for systemic sclerosis. Joint Bone Spine2007; 74:577–83.
3.
FredholmBBIjzermanAPJacobsonKAKlotzKNLindenJ. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev2001; 53:527–52.
4.
ChanESLCronsteinBN. Molecular action of methotrexate in inflammatory diseases. Arthritis Res2002; 4:266–73.
5.
ChanESLFernandezPMerchantAA. Adenosine A2A receptors in diffuse dermal fibrosis: Pathogenic role in human dermal fibroblasts and in a murine model of scleroderma. Arthritis Rheum2006; 54:2632–42.
6.
MontesinosMCDesaiAChenJFYeeHSchwarzschildMAFinkJSCronsteinBN. Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A2A receptors. Am J Pathol2002; 160: 2009–18.
7.
MontesinosMCGadangiPLongakerM. Wound healing is accelerated by agonists of adenosine A2 (Gαs-linked) receptors. J Exp Med1997; 186:1615–20.
8.
DeckertJNothenMFrankePDelmoCFritzeJKnappsMMaierWBeckmannHProppingP. Systematic mutation screening and association study of the Al and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry1998; 3: 81–85.
9.
HamiltonSPSlagerSLDe LeonABHeimanGAKleinDFHodgeSEWeissmanMMFyerAJKnowlesJA. Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology2004; 29:558–65.
10.
AlseneKDeckertJSandPDe WitH. Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology2003; 28:1694–702.
11.
KimSHKimYKParkHWYeYMMinKUParkHS. Adenosine deaminase and adenosine receptor polymorphisms in aspirin-intolerant asthma. Respir Med2009; 103:356–63.
12.
CharlesBAConleyYPChenG. Variants of the adenosine A2A receptor gene are protective against proliferative diabetic retinopathy in patients with type 1 diabetes. Ophthalmic Res2010; 46:1–8.
DudbridgeF. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered2008; 66:87–98.
15.
FonsecaCLindahlGEPonticosM. A polymorphism in the CTGF promoter region associated with systemic sclerosis. N Engl J Med2007; 357:1210–20.
16.
GourhPTanFKAssassiSAhnCWMcNearneyTAFischbachMArnettFCMayesMD. Association of the PTPN22 R620W polymorphism with anti-topoisomerase I-and anticentromere antibody-positive systemic sclerosis. Arthritis Rheum2006; 54:3945–53.
17.
RuedaBSimeonCHesselstrandR. A large multicentre analysis of CTGF-2945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype. Ann Rheum Dis2009; 68:1618–20.
18.
WipffJAllanoreYKahanA. Lack of association between the protein tyrosine phosphatase non-receptor 22 (PTPN22)* 620W allele and systemic sclerosis in the French Caucasian population. Ann Rheum Dis2006; 65:1230–32.
19.
ChildsEHohoffCDeckertJXuKBadnerJDe WitH. Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology2008; 33:2791–800.
